nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—Irinotecan—stomach cancer	0.376	1	CrCtD
Topotecan—Topoisomerase Inhibitors—Irinotecan—stomach cancer	0.192	0.49	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Epirubicin—stomach cancer	0.104	0.265	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Doxorubicin—stomach cancer	0.096	0.245	CiPCiCtD
Topotecan—TOP1MT—Irinotecan—stomach cancer	0.095	0.516	CbGbCtD
Topotecan—TOP1—Irinotecan—stomach cancer	0.0545	0.296	CbGbCtD
Topotecan—ABCB1—Mitomycin—stomach cancer	0.00727	0.0395	CbGbCtD
Topotecan—ABCG2—Irinotecan—stomach cancer	0.00517	0.0281	CbGbCtD
Topotecan—ABCG2—Fluorouracil—stomach cancer	0.00497	0.027	CbGbCtD
Topotecan—ABCG2—Docetaxel—stomach cancer	0.00379	0.0206	CbGbCtD
Topotecan—ABCG2—Doxorubicin—stomach cancer	0.00283	0.0154	CbGbCtD
Topotecan—ABCG2—Methotrexate—stomach cancer	0.00274	0.0149	CbGbCtD
Topotecan—ABCB1—Irinotecan—stomach cancer	0.00187	0.0101	CbGbCtD
Topotecan—ABCB1—Docetaxel—stomach cancer	0.00137	0.00743	CbGbCtD
Topotecan—CYP3A4—Irinotecan—stomach cancer	0.00112	0.00607	CbGbCtD
Topotecan—ABCB1—Doxorubicin—stomach cancer	0.00102	0.00554	CbGbCtD
Topotecan—ABCB1—Methotrexate—stomach cancer	0.000987	0.00536	CbGbCtD
Topotecan—CYP3A4—Docetaxel—stomach cancer	0.000819	0.00445	CbGbCtD
Topotecan—CYP3A4—Doxorubicin—stomach cancer	0.000611	0.00332	CbGbCtD
Topotecan—TOP1MT—endocrine gland—stomach cancer	0.00033	0.125	CbGeAlD
Topotecan—TOP1MT—liver—stomach cancer	0.000298	0.112	CbGeAlD
Topotecan—TOP1—smooth muscle tissue—stomach cancer	0.000267	0.101	CbGeAlD
Topotecan—TOP1—pancreas—stomach cancer	0.000247	0.0931	CbGeAlD
Topotecan—TOP1MT—lymph node—stomach cancer	0.000228	0.0861	CbGeAlD
Topotecan—TOP1—bone marrow—stomach cancer	0.000194	0.0733	CbGeAlD
Topotecan—TOP1—liver—stomach cancer	0.000157	0.0593	CbGeAlD
Topotecan—TOP1—lymph node—stomach cancer	0.00012	0.0454	CbGeAlD
Topotecan—Irinotecan—ALB—stomach cancer	0.000108	1	CrCbGaD
Topotecan—ABCB1—blood vessel—stomach cancer	9.96e-05	0.0376	CbGeAlD
Topotecan—CYP3A4—hematopoietic system—stomach cancer	7.49e-05	0.0283	CbGeAlD
Topotecan—ABCG2—bone marrow—stomach cancer	6.9e-05	0.026	CbGeAlD
Topotecan—ABCG2—liver—stomach cancer	5.57e-05	0.021	CbGeAlD
Topotecan—ABCB1—hematopoietic system—stomach cancer	5.3e-05	0.02	CbGeAlD
Topotecan—CYP3A4—digestive system—stomach cancer	5.21e-05	0.0197	CbGeAlD
Topotecan—ABCB1—epithelium—stomach cancer	4.85e-05	0.0183	CbGeAlD
Topotecan—ABCB1—pancreas—stomach cancer	4.32e-05	0.0163	CbGeAlD
Topotecan—CYP3A4—endocrine gland—stomach cancer	4.31e-05	0.0162	CbGeAlD
Topotecan—ABCG2—lymph node—stomach cancer	4.27e-05	0.0161	CbGeAlD
Topotecan—CYP3A4—liver—stomach cancer	3.88e-05	0.0146	CbGeAlD
Topotecan—ABCB1—lymphoid tissue—stomach cancer	3.73e-05	0.0141	CbGeAlD
Topotecan—ABCB1—digestive system—stomach cancer	3.69e-05	0.0139	CbGeAlD
Topotecan—ABCB1—bone marrow—stomach cancer	3.4e-05	0.0128	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	3.32e-05	0.00427	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	3.17e-05	0.00407	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	3.16e-05	0.00407	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYT1—stomach cancer	3.12e-05	0.00401	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—RORA—stomach cancer	3.1e-05	0.00399	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	3.07e-05	0.00394	CbGpPWpGaD
Topotecan—ABCB1—endocrine gland—stomach cancer	3.05e-05	0.0115	CbGeAlD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—stomach cancer	3.04e-05	0.00391	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—JUN—stomach cancer	3.04e-05	0.0039	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	2.99e-05	0.00385	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—HMOX1—stomach cancer	2.97e-05	0.00382	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	2.93e-05	0.00377	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	2.9e-05	0.00373	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—MAPK8—stomach cancer	2.87e-05	0.00369	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—SMAD4—stomach cancer	2.85e-05	0.00367	CbGpPWpGaD
Topotecan—Hypersensitivity—Fluorouracil—stomach cancer	2.83e-05	0.000764	CcSEcCtD
Topotecan—Haemoglobin—Methotrexate—stomach cancer	2.83e-05	0.000764	CcSEcCtD
Topotecan—Haemorrhage—Methotrexate—stomach cancer	2.82e-05	0.00076	CcSEcCtD
Topotecan—Sweating—Epirubicin—stomach cancer	2.81e-05	0.000759	CcSEcCtD
Topotecan—Arthralgia—Capecitabine—stomach cancer	2.8e-05	0.000756	CcSEcCtD
Topotecan—Myalgia—Capecitabine—stomach cancer	2.8e-05	0.000756	CcSEcCtD
Topotecan—Chest pain—Capecitabine—stomach cancer	2.8e-05	0.000756	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—NPM1—stomach cancer	2.8e-05	0.0036	CbGpPWpGaD
Topotecan—Pharyngitis—Methotrexate—stomach cancer	2.79e-05	0.000754	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	2.78e-05	0.000751	CcSEcCtD
Topotecan—Hepatobiliary disease—Epirubicin—stomach cancer	2.78e-05	0.000749	CcSEcCtD
Topotecan—Anaphylactic shock—Docetaxel—stomach cancer	2.78e-05	0.000749	CcSEcCtD
Topotecan—Weight increased—Doxorubicin—stomach cancer	2.77e-05	0.000748	CcSEcCtD
Topotecan—Discomfort—Capecitabine—stomach cancer	2.77e-05	0.000747	CcSEcCtD
Topotecan—Epistaxis—Epirubicin—stomach cancer	2.77e-05	0.000747	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	2.76e-05	0.00355	CbGpPWpGaD
Topotecan—Infection—Docetaxel—stomach cancer	2.76e-05	0.000744	CcSEcCtD
Topotecan—ABCB1—liver—stomach cancer	2.75e-05	0.0104	CbGeAlD
Topotecan—Diarrhoea—Irinotecan—stomach cancer	2.75e-05	0.000741	CcSEcCtD
Topotecan—Pneumonia—Doxorubicin—stomach cancer	2.73e-05	0.000737	CcSEcCtD
Topotecan—Nervous system disorder—Docetaxel—stomach cancer	2.72e-05	0.000734	CcSEcCtD
Topotecan—Pruritus—Fluorouracil—stomach cancer	2.72e-05	0.000734	CcSEcCtD
Topotecan—Thrombocytopenia—Docetaxel—stomach cancer	2.72e-05	0.000733	CcSEcCtD
Topotecan—Infestation—Doxorubicin—stomach cancer	2.72e-05	0.000733	CcSEcCtD
Topotecan—Infestation NOS—Doxorubicin—stomach cancer	2.72e-05	0.000733	CcSEcCtD
Topotecan—Skin disorder—Docetaxel—stomach cancer	2.7e-05	0.000727	CcSEcCtD
Topotecan—Infection—Capecitabine—stomach cancer	2.67e-05	0.00072	CcSEcCtD
Topotecan—Neuropathy peripheral—Doxorubicin—stomach cancer	2.66e-05	0.000718	CcSEcCtD
Topotecan—Dizziness—Irinotecan—stomach cancer	2.66e-05	0.000716	CcSEcCtD
Topotecan—Haemoglobin—Epirubicin—stomach cancer	2.65e-05	0.000715	CcSEcCtD
Topotecan—Stomatitis—Doxorubicin—stomach cancer	2.65e-05	0.000714	CcSEcCtD
Topotecan—Anorexia—Docetaxel—stomach cancer	2.65e-05	0.000714	CcSEcCtD
Topotecan—Rhinitis—Epirubicin—stomach cancer	2.64e-05	0.000713	CcSEcCtD
Topotecan—Nervous system disorder—Capecitabine—stomach cancer	2.64e-05	0.000711	CcSEcCtD
Topotecan—Haemorrhage—Epirubicin—stomach cancer	2.64e-05	0.000711	CcSEcCtD
Topotecan—Diarrhoea—Fluorouracil—stomach cancer	2.63e-05	0.00071	CcSEcCtD
Topotecan—Thrombocytopenia—Capecitabine—stomach cancer	2.63e-05	0.00071	CcSEcCtD
Topotecan—Hypoaesthesia—Epirubicin—stomach cancer	2.62e-05	0.000707	CcSEcCtD
Topotecan—Pharyngitis—Epirubicin—stomach cancer	2.62e-05	0.000706	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.61e-05	0.00336	CbGpPWpGaD
Topotecan—Skin disorder—Capecitabine—stomach cancer	2.61e-05	0.000704	CcSEcCtD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—stomach cancer	2.61e-05	0.00336	CbGpPWpGaD
Topotecan—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	2.61e-05	0.00335	CbGpPWpGaD
Topotecan—Sweating—Doxorubicin—stomach cancer	2.6e-05	0.000702	CcSEcCtD
Topotecan—Hyperhidrosis—Capecitabine—stomach cancer	2.6e-05	0.000701	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—CLCN3—stomach cancer	2.57e-05	0.00331	CbGpPWpGaD
Topotecan—Hepatobiliary disease—Doxorubicin—stomach cancer	2.57e-05	0.000693	CcSEcCtD
Topotecan—Epistaxis—Doxorubicin—stomach cancer	2.56e-05	0.000691	CcSEcCtD
Topotecan—Anorexia—Capecitabine—stomach cancer	2.56e-05	0.000691	CcSEcCtD
Topotecan—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	2.56e-05	0.00329	CbGpPWpGaD
Topotecan—Angiopathy—Methotrexate—stomach cancer	2.55e-05	0.000689	CcSEcCtD
Topotecan—Vomiting—Irinotecan—stomach cancer	2.55e-05	0.000689	CcSEcCtD
Topotecan—Immune system disorder—Methotrexate—stomach cancer	2.54e-05	0.000686	CcSEcCtD
Topotecan—Dizziness—Fluorouracil—stomach cancer	2.54e-05	0.000686	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.54e-05	0.00327	CbGpPWpGaD
Topotecan—Mediastinal disorder—Methotrexate—stomach cancer	2.54e-05	0.000685	CcSEcCtD
Topotecan—Rash—Irinotecan—stomach cancer	2.53e-05	0.000683	CcSEcCtD
Topotecan—Dermatitis—Irinotecan—stomach cancer	2.53e-05	0.000682	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Docetaxel—stomach cancer	2.53e-05	0.000682	CcSEcCtD
Topotecan—Chills—Methotrexate—stomach cancer	2.53e-05	0.000682	CcSEcCtD
Topotecan—Headache—Irinotecan—stomach cancer	2.52e-05	0.000679	CcSEcCtD
Topotecan—Paraesthesia—Docetaxel—stomach cancer	2.49e-05	0.000672	CcSEcCtD
Topotecan—Alopecia—Methotrexate—stomach cancer	2.49e-05	0.000671	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.49e-05	0.0032	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.49e-05	0.0032	CbGpPWpGaD
Topotecan—Dyspnoea—Docetaxel—stomach cancer	2.47e-05	0.000668	CcSEcCtD
Topotecan—Malnutrition—Methotrexate—stomach cancer	2.45e-05	0.000661	CcSEcCtD
Topotecan—Haemoglobin—Doxorubicin—stomach cancer	2.45e-05	0.000661	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Capecitabine—stomach cancer	2.45e-05	0.000661	CcSEcCtD
Topotecan—Vomiting—Fluorouracil—stomach cancer	2.45e-05	0.00066	CcSEcCtD
Topotecan—Rhinitis—Doxorubicin—stomach cancer	2.44e-05	0.000659	CcSEcCtD
Topotecan—Dyspepsia—Docetaxel—stomach cancer	2.44e-05	0.000659	CcSEcCtD
Topotecan—Haemorrhage—Doxorubicin—stomach cancer	2.44e-05	0.000658	CcSEcCtD
Topotecan—Hypoaesthesia—Doxorubicin—stomach cancer	2.43e-05	0.000654	CcSEcCtD
Topotecan—Rash—Fluorouracil—stomach cancer	2.42e-05	0.000654	CcSEcCtD
Topotecan—Dermatitis—Fluorouracil—stomach cancer	2.42e-05	0.000654	CcSEcCtD
Topotecan—Pharyngitis—Doxorubicin—stomach cancer	2.42e-05	0.000653	CcSEcCtD
Topotecan—Paraesthesia—Capecitabine—stomach cancer	2.41e-05	0.000651	CcSEcCtD
Topotecan—Decreased appetite—Docetaxel—stomach cancer	2.41e-05	0.000651	CcSEcCtD
Topotecan—Headache—Fluorouracil—stomach cancer	2.41e-05	0.00065	CcSEcCtD
Topotecan—Gastrointestinal disorder—Docetaxel—stomach cancer	2.4e-05	0.000646	CcSEcCtD
Topotecan—Dyspnoea—Capecitabine—stomach cancer	2.4e-05	0.000646	CcSEcCtD
Topotecan—Fatigue—Docetaxel—stomach cancer	2.39e-05	0.000646	CcSEcCtD
Topotecan—Angiopathy—Epirubicin—stomach cancer	2.39e-05	0.000645	CcSEcCtD
Topotecan—Nausea—Irinotecan—stomach cancer	2.39e-05	0.000643	CcSEcCtD
Topotecan—Immune system disorder—Epirubicin—stomach cancer	2.38e-05	0.000642	CcSEcCtD
Topotecan—Mediastinal disorder—Epirubicin—stomach cancer	2.38e-05	0.000641	CcSEcCtD
Topotecan—Pain—Docetaxel—stomach cancer	2.37e-05	0.00064	CcSEcCtD
Topotecan—Constipation—Docetaxel—stomach cancer	2.37e-05	0.00064	CcSEcCtD
Topotecan—Back pain—Methotrexate—stomach cancer	2.37e-05	0.00064	CcSEcCtD
Topotecan—CYP3A4—Irinotecan Pathway—APC—stomach cancer	2.37e-05	0.00305	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.37e-05	0.00304	CbGpPWpGaD
Topotecan—Dyspepsia—Capecitabine—stomach cancer	2.37e-05	0.000638	CcSEcCtD
Topotecan—Chills—Epirubicin—stomach cancer	2.36e-05	0.000638	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.35e-05	0.00302	CbGpPWpGaD
Topotecan—Decreased appetite—Capecitabine—stomach cancer	2.34e-05	0.00063	CcSEcCtD
Topotecan—Alopecia—Epirubicin—stomach cancer	2.33e-05	0.000628	CcSEcCtD
Topotecan—Gastrointestinal disorder—Capecitabine—stomach cancer	2.32e-05	0.000626	CcSEcCtD
Topotecan—Fatigue—Capecitabine—stomach cancer	2.32e-05	0.000625	CcSEcCtD
Topotecan—Constipation—Capecitabine—stomach cancer	2.3e-05	0.00062	CcSEcCtD
Topotecan—Pain—Capecitabine—stomach cancer	2.3e-05	0.00062	CcSEcCtD
Topotecan—Malnutrition—Epirubicin—stomach cancer	2.29e-05	0.000619	CcSEcCtD
Topotecan—Feeling abnormal—Docetaxel—stomach cancer	2.29e-05	0.000617	CcSEcCtD
Topotecan—Nausea—Fluorouracil—stomach cancer	2.28e-05	0.000616	CcSEcCtD
Topotecan—Ill-defined disorder—Methotrexate—stomach cancer	2.27e-05	0.000614	CcSEcCtD
Topotecan—Gastrointestinal pain—Docetaxel—stomach cancer	2.27e-05	0.000612	CcSEcCtD
Topotecan—Anaemia—Methotrexate—stomach cancer	2.27e-05	0.000611	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—stomach cancer	2.26e-05	0.0029	CbGpPWpGaD
Topotecan—Back pain—Epirubicin—stomach cancer	2.22e-05	0.000599	CcSEcCtD
Topotecan—Feeling abnormal—Capecitabine—stomach cancer	2.21e-05	0.000597	CcSEcCtD
Topotecan—Angiopathy—Doxorubicin—stomach cancer	2.21e-05	0.000597	CcSEcCtD
Topotecan—Malaise—Methotrexate—stomach cancer	2.21e-05	0.000596	CcSEcCtD
Topotecan—Muscle spasms—Epirubicin—stomach cancer	2.21e-05	0.000595	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—ENO1—stomach cancer	2.2e-05	0.00283	CbGpPWpGaD
Topotecan—Immune system disorder—Doxorubicin—stomach cancer	2.2e-05	0.000594	CcSEcCtD
Topotecan—Gastrointestinal pain—Capecitabine—stomach cancer	2.2e-05	0.000593	CcSEcCtD
Topotecan—Mediastinal disorder—Doxorubicin—stomach cancer	2.2e-05	0.000593	CcSEcCtD
Topotecan—Body temperature increased—Docetaxel—stomach cancer	2.19e-05	0.000592	CcSEcCtD
Topotecan—Abdominal pain—Docetaxel—stomach cancer	2.19e-05	0.000592	CcSEcCtD
Topotecan—Leukopenia—Methotrexate—stomach cancer	2.19e-05	0.000592	CcSEcCtD
Topotecan—Chills—Doxorubicin—stomach cancer	2.19e-05	0.00059	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.16e-05	0.00277	CbGpPWpGaD
Topotecan—Alopecia—Doxorubicin—stomach cancer	2.15e-05	0.000581	CcSEcCtD
Topotecan—Cough—Methotrexate—stomach cancer	2.14e-05	0.000577	CcSEcCtD
Topotecan—Urticaria—Capecitabine—stomach cancer	2.14e-05	0.000576	CcSEcCtD
Topotecan—Ill-defined disorder—Epirubicin—stomach cancer	2.13e-05	0.000574	CcSEcCtD
Topotecan—Abdominal pain—Capecitabine—stomach cancer	2.12e-05	0.000573	CcSEcCtD
Topotecan—Body temperature increased—Capecitabine—stomach cancer	2.12e-05	0.000573	CcSEcCtD
Topotecan—Malnutrition—Doxorubicin—stomach cancer	2.12e-05	0.000573	CcSEcCtD
Topotecan—Anaemia—Epirubicin—stomach cancer	2.12e-05	0.000572	CcSEcCtD
Topotecan—ABCB1—lymph node—stomach cancer	2.11e-05	0.00795	CbGeAlD
Topotecan—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	2.1e-05	0.0027	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—stomach cancer	2.09e-05	0.00269	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.09e-05	0.00268	CbGpPWpGaD
Topotecan—Chest pain—Methotrexate—stomach cancer	2.09e-05	0.000563	CcSEcCtD
Topotecan—Arthralgia—Methotrexate—stomach cancer	2.09e-05	0.000563	CcSEcCtD
Topotecan—Myalgia—Methotrexate—stomach cancer	2.09e-05	0.000563	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	2.07e-05	0.000559	CcSEcCtD
Topotecan—Malaise—Epirubicin—stomach cancer	2.07e-05	0.000558	CcSEcCtD
Topotecan—Discomfort—Methotrexate—stomach cancer	2.06e-05	0.000556	CcSEcCtD
Topotecan—Leukopenia—Epirubicin—stomach cancer	2.05e-05	0.000554	CcSEcCtD
Topotecan—Back pain—Doxorubicin—stomach cancer	2.05e-05	0.000554	CcSEcCtD
Topotecan—Hypersensitivity—Docetaxel—stomach cancer	2.05e-05	0.000552	CcSEcCtD
Topotecan—Muscle spasms—Doxorubicin—stomach cancer	2.04e-05	0.000551	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—TP53—stomach cancer	2e-05	0.00258	CbGpPWpGaD
Topotecan—Cough—Epirubicin—stomach cancer	2e-05	0.00054	CcSEcCtD
Topotecan—Anaphylactic shock—Methotrexate—stomach cancer	2e-05	0.00054	CcSEcCtD
Topotecan—Asthenia—Docetaxel—stomach cancer	1.99e-05	0.000537	CcSEcCtD
Topotecan—Infection—Methotrexate—stomach cancer	1.99e-05	0.000536	CcSEcCtD
Topotecan—Hypersensitivity—Capecitabine—stomach cancer	1.98e-05	0.000534	CcSEcCtD
Topotecan—ABCB1—ABC-family proteins mediated transport—APOA1—stomach cancer	1.98e-05	0.00254	CbGpPWpGaD
Topotecan—Ill-defined disorder—Doxorubicin—stomach cancer	1.97e-05	0.000531	CcSEcCtD
Topotecan—Pruritus—Docetaxel—stomach cancer	1.96e-05	0.00053	CcSEcCtD
Topotecan—Nervous system disorder—Methotrexate—stomach cancer	1.96e-05	0.000529	CcSEcCtD
Topotecan—Anaemia—Doxorubicin—stomach cancer	1.96e-05	0.000529	CcSEcCtD
Topotecan—Thrombocytopenia—Methotrexate—stomach cancer	1.96e-05	0.000528	CcSEcCtD
Topotecan—Chest pain—Epirubicin—stomach cancer	1.95e-05	0.000527	CcSEcCtD
Topotecan—Arthralgia—Epirubicin—stomach cancer	1.95e-05	0.000527	CcSEcCtD
Topotecan—Myalgia—Epirubicin—stomach cancer	1.95e-05	0.000527	CcSEcCtD
Topotecan—Skin disorder—Methotrexate—stomach cancer	1.94e-05	0.000524	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	1.94e-05	0.000523	CcSEcCtD
Topotecan—Hyperhidrosis—Methotrexate—stomach cancer	1.93e-05	0.000522	CcSEcCtD
Topotecan—Discomfort—Epirubicin—stomach cancer	1.93e-05	0.000521	CcSEcCtD
Topotecan—Asthenia—Capecitabine—stomach cancer	1.93e-05	0.00052	CcSEcCtD
Topotecan—Malaise—Doxorubicin—stomach cancer	1.91e-05	0.000516	CcSEcCtD
Topotecan—Anorexia—Methotrexate—stomach cancer	1.91e-05	0.000514	CcSEcCtD
Topotecan—Pruritus—Capecitabine—stomach cancer	1.9e-05	0.000513	CcSEcCtD
Topotecan—Leukopenia—Doxorubicin—stomach cancer	1.9e-05	0.000513	CcSEcCtD
Topotecan—Diarrhoea—Docetaxel—stomach cancer	1.9e-05	0.000512	CcSEcCtD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—stomach cancer	1.88e-05	0.00241	CbGpPWpGaD
Topotecan—Anaphylactic shock—Epirubicin—stomach cancer	1.87e-05	0.000505	CcSEcCtD
Topotecan—Infection—Epirubicin—stomach cancer	1.86e-05	0.000502	CcSEcCtD
Topotecan—Cough—Doxorubicin—stomach cancer	1.85e-05	0.0005	CcSEcCtD
Topotecan—Diarrhoea—Capecitabine—stomach cancer	1.84e-05	0.000496	CcSEcCtD
Topotecan—Nervous system disorder—Epirubicin—stomach cancer	1.84e-05	0.000495	CcSEcCtD
Topotecan—Dizziness—Docetaxel—stomach cancer	1.84e-05	0.000495	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—IL6—stomach cancer	1.83e-05	0.00236	CbGpPWpGaD
Topotecan—Thrombocytopenia—Epirubicin—stomach cancer	1.83e-05	0.000495	CcSEcCtD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	1.82e-05	0.00235	CbGpPWpGaD
Topotecan—Musculoskeletal discomfort—Methotrexate—stomach cancer	1.82e-05	0.000492	CcSEcCtD
Topotecan—Skin disorder—Epirubicin—stomach cancer	1.82e-05	0.000491	CcSEcCtD
Topotecan—Hyperhidrosis—Epirubicin—stomach cancer	1.81e-05	0.000488	CcSEcCtD
Topotecan—Chest pain—Doxorubicin—stomach cancer	1.81e-05	0.000488	CcSEcCtD
Topotecan—Myalgia—Doxorubicin—stomach cancer	1.81e-05	0.000488	CcSEcCtD
Topotecan—Arthralgia—Doxorubicin—stomach cancer	1.81e-05	0.000488	CcSEcCtD
Topotecan—Paraesthesia—Methotrexate—stomach cancer	1.8e-05	0.000485	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	1.79e-05	0.000484	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—stomach cancer	1.79e-05	0.0023	CbGpPWpGaD
Topotecan—Discomfort—Doxorubicin—stomach cancer	1.79e-05	0.000482	CcSEcCtD
Topotecan—Anorexia—Epirubicin—stomach cancer	1.78e-05	0.000481	CcSEcCtD
Topotecan—Dyspnoea—Methotrexate—stomach cancer	1.78e-05	0.000481	CcSEcCtD
Topotecan—Dizziness—Capecitabine—stomach cancer	1.78e-05	0.000479	CcSEcCtD
Topotecan—Vomiting—Docetaxel—stomach cancer	1.76e-05	0.000476	CcSEcCtD
Topotecan—Dyspepsia—Methotrexate—stomach cancer	1.76e-05	0.000475	CcSEcCtD
Topotecan—Rash—Docetaxel—stomach cancer	1.75e-05	0.000472	CcSEcCtD
Topotecan—Dermatitis—Docetaxel—stomach cancer	1.75e-05	0.000472	CcSEcCtD
Topotecan—Decreased appetite—Methotrexate—stomach cancer	1.74e-05	0.000469	CcSEcCtD
Topotecan—Headache—Docetaxel—stomach cancer	1.74e-05	0.000469	CcSEcCtD
Topotecan—Anaphylactic shock—Doxorubicin—stomach cancer	1.73e-05	0.000467	CcSEcCtD
Topotecan—Gastrointestinal disorder—Methotrexate—stomach cancer	1.73e-05	0.000466	CcSEcCtD
Topotecan—Fatigue—Methotrexate—stomach cancer	1.72e-05	0.000465	CcSEcCtD
Topotecan—Infection—Doxorubicin—stomach cancer	1.72e-05	0.000464	CcSEcCtD
Topotecan—Pain—Methotrexate—stomach cancer	1.71e-05	0.000462	CcSEcCtD
Topotecan—Vomiting—Capecitabine—stomach cancer	1.71e-05	0.000461	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Epirubicin—stomach cancer	1.71e-05	0.00046	CcSEcCtD
Topotecan—Nervous system disorder—Doxorubicin—stomach cancer	1.7e-05	0.000458	CcSEcCtD
Topotecan—Thrombocytopenia—Doxorubicin—stomach cancer	1.7e-05	0.000458	CcSEcCtD
Topotecan—Rash—Capecitabine—stomach cancer	1.69e-05	0.000457	CcSEcCtD
Topotecan—Dermatitis—Capecitabine—stomach cancer	1.69e-05	0.000457	CcSEcCtD
Topotecan—Headache—Capecitabine—stomach cancer	1.68e-05	0.000454	CcSEcCtD
Topotecan—Skin disorder—Doxorubicin—stomach cancer	1.68e-05	0.000454	CcSEcCtD
Topotecan—Paraesthesia—Epirubicin—stomach cancer	1.68e-05	0.000454	CcSEcCtD
Topotecan—Hyperhidrosis—Doxorubicin—stomach cancer	1.67e-05	0.000452	CcSEcCtD
Topotecan—Dyspnoea—Epirubicin—stomach cancer	1.67e-05	0.00045	CcSEcCtD
Topotecan—Anorexia—Doxorubicin—stomach cancer	1.65e-05	0.000445	CcSEcCtD
Topotecan—Nausea—Docetaxel—stomach cancer	1.65e-05	0.000445	CcSEcCtD
Topotecan—Feeling abnormal—Methotrexate—stomach cancer	1.65e-05	0.000445	CcSEcCtD
Topotecan—Dyspepsia—Epirubicin—stomach cancer	1.65e-05	0.000445	CcSEcCtD
Topotecan—Gastrointestinal pain—Methotrexate—stomach cancer	1.64e-05	0.000441	CcSEcCtD
Topotecan—Decreased appetite—Epirubicin—stomach cancer	1.63e-05	0.000439	CcSEcCtD
Topotecan—ABCG2—Fluoropyrimidine Activity—TP53—stomach cancer	1.62e-05	0.00208	CbGpPWpGaD
Topotecan—Gastrointestinal disorder—Epirubicin—stomach cancer	1.62e-05	0.000436	CcSEcCtD
Topotecan—Fatigue—Epirubicin—stomach cancer	1.61e-05	0.000435	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—HMOX1—stomach cancer	1.61e-05	0.00207	CbGpPWpGaD
Topotecan—Constipation—Epirubicin—stomach cancer	1.6e-05	0.000432	CcSEcCtD
Topotecan—Pain—Epirubicin—stomach cancer	1.6e-05	0.000432	CcSEcCtD
Topotecan—Nausea—Capecitabine—stomach cancer	1.6e-05	0.000431	CcSEcCtD
Topotecan—Urticaria—Methotrexate—stomach cancer	1.59e-05	0.000429	CcSEcCtD
Topotecan—Body temperature increased—Methotrexate—stomach cancer	1.58e-05	0.000427	CcSEcCtD
Topotecan—Abdominal pain—Methotrexate—stomach cancer	1.58e-05	0.000427	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	1.58e-05	0.000426	CcSEcCtD
Topotecan—Paraesthesia—Doxorubicin—stomach cancer	1.56e-05	0.00042	CcSEcCtD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	1.55e-05	0.00199	CbGpPWpGaD
Topotecan—Dyspnoea—Doxorubicin—stomach cancer	1.54e-05	0.000417	CcSEcCtD
Topotecan—Feeling abnormal—Epirubicin—stomach cancer	1.54e-05	0.000416	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—SMAD4—stomach cancer	1.54e-05	0.00198	CbGpPWpGaD
Topotecan—Gastrointestinal pain—Epirubicin—stomach cancer	1.53e-05	0.000413	CcSEcCtD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	1.53e-05	0.00196	CbGpPWpGaD
Topotecan—Dyspepsia—Doxorubicin—stomach cancer	1.52e-05	0.000411	CcSEcCtD
Topotecan—Decreased appetite—Doxorubicin—stomach cancer	1.51e-05	0.000406	CcSEcCtD
Topotecan—Gastrointestinal disorder—Doxorubicin—stomach cancer	1.5e-05	0.000403	CcSEcCtD
Topotecan—Fatigue—Doxorubicin—stomach cancer	1.49e-05	0.000403	CcSEcCtD
Topotecan—Urticaria—Epirubicin—stomach cancer	1.49e-05	0.000401	CcSEcCtD
Topotecan—Pain—Doxorubicin—stomach cancer	1.48e-05	0.0004	CcSEcCtD
Topotecan—Constipation—Doxorubicin—stomach cancer	1.48e-05	0.0004	CcSEcCtD
Topotecan—Abdominal pain—Epirubicin—stomach cancer	1.48e-05	0.000399	CcSEcCtD
Topotecan—Body temperature increased—Epirubicin—stomach cancer	1.48e-05	0.000399	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BID—stomach cancer	1.48e-05	0.0019	CbGpPWpGaD
Topotecan—Hypersensitivity—Methotrexate—stomach cancer	1.47e-05	0.000398	CcSEcCtD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—stomach cancer	1.44e-05	0.00185	CbGpPWpGaD
Topotecan—Asthenia—Methotrexate—stomach cancer	1.44e-05	0.000387	CcSEcCtD
Topotecan—Feeling abnormal—Doxorubicin—stomach cancer	1.43e-05	0.000385	CcSEcCtD
Topotecan—Gastrointestinal pain—Doxorubicin—stomach cancer	1.42e-05	0.000382	CcSEcCtD
Topotecan—Pruritus—Methotrexate—stomach cancer	1.42e-05	0.000382	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—JUN—stomach cancer	1.41e-05	0.00181	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—CLCN3—stomach cancer	1.39e-05	0.00179	CbGpPWpGaD
Topotecan—Hypersensitivity—Epirubicin—stomach cancer	1.38e-05	0.000372	CcSEcCtD
Topotecan—Urticaria—Doxorubicin—stomach cancer	1.38e-05	0.000371	CcSEcCtD
Topotecan—Abdominal pain—Doxorubicin—stomach cancer	1.37e-05	0.000369	CcSEcCtD
Topotecan—Body temperature increased—Doxorubicin—stomach cancer	1.37e-05	0.000369	CcSEcCtD
Topotecan—Diarrhoea—Methotrexate—stomach cancer	1.37e-05	0.000369	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—stomach cancer	1.36e-05	0.00175	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FST—stomach cancer	1.36e-05	0.00175	CbGpPWpGaD
Topotecan—Asthenia—Epirubicin—stomach cancer	1.34e-05	0.000362	CcSEcCtD
Topotecan—Pruritus—Epirubicin—stomach cancer	1.32e-05	0.000357	CcSEcCtD
Topotecan—Dizziness—Methotrexate—stomach cancer	1.32e-05	0.000357	CcSEcCtD
Topotecan—ABCB1—Allograft Rejection—IL10—stomach cancer	1.3e-05	0.00167	CbGpPWpGaD
Topotecan—Diarrhoea—Epirubicin—stomach cancer	1.28e-05	0.000346	CcSEcCtD
Topotecan—Hypersensitivity—Doxorubicin—stomach cancer	1.28e-05	0.000344	CcSEcCtD
Topotecan—Vomiting—Methotrexate—stomach cancer	1.27e-05	0.000343	CcSEcCtD
Topotecan—Rash—Methotrexate—stomach cancer	1.26e-05	0.00034	CcSEcCtD
Topotecan—Dermatitis—Methotrexate—stomach cancer	1.26e-05	0.00034	CcSEcCtD
Topotecan—Headache—Methotrexate—stomach cancer	1.25e-05	0.000338	CcSEcCtD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	1.25e-05	0.00161	CbGpPWpGaD
Topotecan—Asthenia—Doxorubicin—stomach cancer	1.24e-05	0.000335	CcSEcCtD
Topotecan—Dizziness—Epirubicin—stomach cancer	1.24e-05	0.000334	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	1.23e-05	0.00158	CbGpPWpGaD
Topotecan—Pruritus—Doxorubicin—stomach cancer	1.23e-05	0.000331	CcSEcCtD
Topotecan—ABCG2—Metabolism—ACAD8—stomach cancer	1.2e-05	0.00155	CbGpPWpGaD
Topotecan—Vomiting—Epirubicin—stomach cancer	1.19e-05	0.000321	CcSEcCtD
Topotecan—Nausea—Methotrexate—stomach cancer	1.19e-05	0.000321	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	1.19e-05	0.00152	CbGpPWpGaD
Topotecan—Diarrhoea—Doxorubicin—stomach cancer	1.19e-05	0.00032	CcSEcCtD
Topotecan—Rash—Epirubicin—stomach cancer	1.18e-05	0.000318	CcSEcCtD
Topotecan—Dermatitis—Epirubicin—stomach cancer	1.18e-05	0.000318	CcSEcCtD
Topotecan—Headache—Epirubicin—stomach cancer	1.17e-05	0.000316	CcSEcCtD
Topotecan—Dizziness—Doxorubicin—stomach cancer	1.15e-05	0.000309	CcSEcCtD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	1.12e-05	0.00145	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	1.12e-05	0.00144	CbGpPWpGaD
Topotecan—Nausea—Epirubicin—stomach cancer	1.11e-05	0.0003	CcSEcCtD
Topotecan—Vomiting—Doxorubicin—stomach cancer	1.1e-05	0.000297	CcSEcCtD
Topotecan—Rash—Doxorubicin—stomach cancer	1.09e-05	0.000295	CcSEcCtD
Topotecan—Dermatitis—Doxorubicin—stomach cancer	1.09e-05	0.000294	CcSEcCtD
Topotecan—Headache—Doxorubicin—stomach cancer	1.09e-05	0.000293	CcSEcCtD
Topotecan—ABCG2—Metabolism—GMPR2—stomach cancer	1.07e-05	0.00138	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	1.03e-05	0.00132	CbGpPWpGaD
Topotecan—Nausea—Doxorubicin—stomach cancer	1.03e-05	0.000278	CcSEcCtD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—stomach cancer	1.01e-05	0.0013	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—IDH3B—stomach cancer	9.82e-06	0.00126	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SUCLG1—stomach cancer	9.82e-06	0.00126	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—stomach cancer	9.67e-06	0.00124	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	9.23e-06	0.00119	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NDUFS1—stomach cancer	9.13e-06	0.00117	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NDUFV1—stomach cancer	9.13e-06	0.00117	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CASP8—stomach cancer	8.97e-06	0.00115	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	8.79e-06	0.00113	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—BLVRB—stomach cancer	8.14e-06	0.00105	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PGLS—stomach cancer	8.14e-06	0.00105	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	8.03e-06	0.00103	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—stomach cancer	7.77e-06	0.000998	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPAP2A—stomach cancer	7.76e-06	0.000998	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—JUN—stomach cancer	7.61e-06	0.000979	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CXCL8—stomach cancer	7.09e-06	0.000912	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CA1—stomach cancer	6.92e-06	0.000889	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—FBP1—stomach cancer	6.92e-06	0.000889	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CKB—stomach cancer	6.92e-06	0.000889	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NDUFA2—stomach cancer	6.92e-06	0.000889	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL1B—stomach cancer	6.8e-06	0.000875	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTT1—stomach cancer	6.73e-06	0.000866	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	6.7e-06	0.000862	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	6.65e-06	0.000856	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	6.65e-06	0.000855	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	6.59e-06	0.000848	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ACAD8—stomach cancer	6.51e-06	0.000837	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLIN2—stomach cancer	6.5e-06	0.000836	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	6.48e-06	0.000832	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	6.38e-06	0.000821	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CA2—stomach cancer	6.33e-06	0.000813	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PGAM1—stomach cancer	6.17e-06	0.000793	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NT5E—stomach cancer	6.17e-06	0.000793	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	6.05e-06	0.000778	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALDH7A1—stomach cancer	5.88e-06	0.000756	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLCE1—stomach cancer	5.88e-06	0.000756	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GMPR2—stomach cancer	5.8e-06	0.000746	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—stomach cancer	5.76e-06	0.00074	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—UMPS—stomach cancer	5.64e-06	0.000725	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SUCLG1—stomach cancer	5.31e-06	0.000682	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—IDH3B—stomach cancer	5.31e-06	0.000682	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PDHA1—stomach cancer	5.24e-06	0.000674	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ECHS1—stomach cancer	5.24e-06	0.000674	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	5.05e-06	0.000649	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—HMOX1—stomach cancer	5.04e-06	0.000649	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TNF—stomach cancer	4.94e-06	0.000635	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NDUFS1—stomach cancer	4.94e-06	0.000634	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NDUFV1—stomach cancer	4.94e-06	0.000634	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TYMP—stomach cancer	4.93e-06	0.000634	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—FADS1—stomach cancer	4.93e-06	0.000634	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	4.75e-06	0.000611	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTP1—stomach cancer	4.67e-06	0.0006	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SREBF2—stomach cancer	4.62e-06	0.000593	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	4.6e-06	0.000592	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—RORA—stomach cancer	4.56e-06	0.000586	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	4.43e-06	0.000569	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—BLVRB—stomach cancer	4.4e-06	0.000565	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PGLS—stomach cancer	4.4e-06	0.000565	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTM1—stomach cancer	4.29e-06	0.000551	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALDOB—stomach cancer	4.27e-06	0.000549	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	4.23e-06	0.000544	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPAP2A—stomach cancer	4.2e-06	0.000539	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ACAD8—stomach cancer	4.01e-06	0.000516	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALOX5—stomach cancer	3.97e-06	0.000511	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—DPYD—stomach cancer	3.91e-06	0.000503	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—APOA1—stomach cancer	3.82e-06	0.000492	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FBP1—stomach cancer	3.74e-06	0.000481	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CKB—stomach cancer	3.74e-06	0.000481	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NDUFA2—stomach cancer	3.74e-06	0.000481	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CA1—stomach cancer	3.74e-06	0.000481	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	3.69e-06	0.000474	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	3.61e-06	0.000464	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GMPR2—stomach cancer	3.58e-06	0.00046	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLIN2—stomach cancer	3.52e-06	0.000452	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTT1—stomach cancer	3.46e-06	0.000444	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CA2—stomach cancer	3.42e-06	0.00044	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	3.42e-06	0.000439	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2A6—stomach cancer	3.42e-06	0.000439	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PGAM1—stomach cancer	3.33e-06	0.000429	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NT5E—stomach cancer	3.33e-06	0.000429	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKR1C3—stomach cancer	3.32e-06	0.000427	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SUCLG1—stomach cancer	3.27e-06	0.00042	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—IDH3B—stomach cancer	3.27e-06	0.00042	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	3.26e-06	0.000419	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	3.25e-06	0.000418	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ENO1—stomach cancer	3.24e-06	0.000416	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALDH7A1—stomach cancer	3.18e-06	0.000409	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLCE1—stomach cancer	3.18e-06	0.000409	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	3.15e-06	0.000405	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	3.08e-06	0.000396	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—UMPS—stomach cancer	3.05e-06	0.000392	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NDUFV1—stomach cancer	3.04e-06	0.000391	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NDUFS1—stomach cancer	3.04e-06	0.000391	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ALB—stomach cancer	3.03e-06	0.000389	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CD44—stomach cancer	2.87e-06	0.000369	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	2.84e-06	0.000365	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PDHA1—stomach cancer	2.83e-06	0.000364	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ECHS1—stomach cancer	2.83e-06	0.000364	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.73e-06	0.000351	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PGLS—stomach cancer	2.71e-06	0.000348	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—BLVRB—stomach cancer	2.71e-06	0.000348	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.69e-06	0.000346	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FADS1—stomach cancer	2.66e-06	0.000343	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TYMP—stomach cancer	2.66e-06	0.000343	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.62e-06	0.000336	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.59e-06	0.000332	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.56e-06	0.000329	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.56e-06	0.000329	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SREBF2—stomach cancer	2.5e-06	0.000321	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—RORA—stomach cancer	2.47e-06	0.000317	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPP2R1A—stomach cancer	2.44e-06	0.000314	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.44e-06	0.000313	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.42e-06	0.000311	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTP1—stomach cancer	2.4e-06	0.000308	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HMOX1—stomach cancer	2.36e-06	0.000304	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALDOB—stomach cancer	2.31e-06	0.000297	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FBP1—stomach cancer	2.3e-06	0.000296	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.3e-06	0.000296	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CKB—stomach cancer	2.3e-06	0.000296	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CA1—stomach cancer	2.3e-06	0.000296	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TYMS—stomach cancer	2.23e-06	0.000286	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.22e-06	0.000285	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTM1—stomach cancer	2.2e-06	0.000283	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLIN2—stomach cancer	2.17e-06	0.000279	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALOX5—stomach cancer	2.15e-06	0.000276	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.15e-06	0.000276	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—DPYD—stomach cancer	2.11e-06	0.000272	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CA2—stomach cancer	2.11e-06	0.000271	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ERCC2—stomach cancer	2.07e-06	0.000266	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.07e-06	0.000266	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NT5E—stomach cancer	2.05e-06	0.000264	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PGAM1—stomach cancer	2.05e-06	0.000264	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLCE1—stomach cancer	1.96e-06	0.000252	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.96e-06	0.000252	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTHFR—stomach cancer	1.95e-06	0.00025	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UMPS—stomach cancer	1.88e-06	0.000241	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTT1—stomach cancer	1.87e-06	0.00024	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2A6—stomach cancer	1.85e-06	0.000237	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKR1C3—stomach cancer	1.8e-06	0.000231	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAV1—stomach cancer	1.79e-06	0.000231	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOA1—stomach cancer	1.79e-06	0.00023	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ENO1—stomach cancer	1.75e-06	0.000225	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PDHA1—stomach cancer	1.75e-06	0.000225	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ECHS1—stomach cancer	1.75e-06	0.000225	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TYMP—stomach cancer	1.64e-06	0.000211	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FADS1—stomach cancer	1.64e-06	0.000211	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.64e-06	0.000211	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARG—stomach cancer	1.58e-06	0.000203	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CD44—stomach cancer	1.55e-06	0.0002	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SREBF2—stomach cancer	1.54e-06	0.000198	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—RORA—stomach cancer	1.52e-06	0.000195	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALDOB—stomach cancer	1.42e-06	0.000183	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALB—stomach cancer	1.42e-06	0.000182	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NOS3—stomach cancer	1.36e-06	0.000174	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALOX5—stomach cancer	1.32e-06	0.00017	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.32e-06	0.00017	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—DPYD—stomach cancer	1.3e-06	0.000167	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTP1—stomach cancer	1.3e-06	0.000167	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMOX1—stomach cancer	1.28e-06	0.000164	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—stomach cancer	1.24e-06	0.00016	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TYMS—stomach cancer	1.2e-06	0.000155	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTM1—stomach cancer	1.19e-06	0.000153	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTT1—stomach cancer	1.15e-06	0.000148	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.14e-06	0.000146	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ERCC2—stomach cancer	1.12e-06	0.000144	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.11e-06	0.000142	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ENO1—stomach cancer	1.08e-06	0.000139	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTHFR—stomach cancer	1.05e-06	0.000135	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAV1—stomach cancer	9.7e-07	0.000125	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOA1—stomach cancer	9.68e-07	0.000124	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CD44—stomach cancer	9.57e-07	0.000123	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARG—stomach cancer	8.53e-07	0.00011	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPP2R1A—stomach cancer	8.14e-07	0.000105	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTP1—stomach cancer	7.98e-07	0.000103	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMOX1—stomach cancer	7.87e-07	0.000101	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALB—stomach cancer	7.67e-07	9.86e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CA—stomach cancer	7.64e-07	9.82e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TYMS—stomach cancer	7.42e-07	9.54e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NOS3—stomach cancer	7.34e-07	9.43e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM1—stomach cancer	7.33e-07	9.43e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ERCC2—stomach cancer	6.9e-07	8.86e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—stomach cancer	6.71e-07	8.63e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTHFR—stomach cancer	6.48e-07	8.33e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAV1—stomach cancer	5.98e-07	7.69e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOA1—stomach cancer	5.96e-07	7.67e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARG—stomach cancer	5.26e-07	6.76e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALB—stomach cancer	4.73e-07	6.08e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NOS3—stomach cancer	4.52e-07	5.81e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—stomach cancer	4.13e-07	5.32e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CA—stomach cancer	4.13e-07	5.31e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.54e-07	3.27e-05	CbGpPWpGaD
